Christina Chapman, M.D., sits down for a discussion on diversity, equity and inclusion in medicine.
Demsky joined the University of Michigan Rogel Cancer Center communications team in 2019. Prior to that he served as director of communications for the University of Michigan's Life Sciences Institute and science editor for Medicine at Michigan Magazine.
Three early-stage cancer drug projects receive pilot grants to help them advance from the bench toward the bedside.
Better shared decision-making could help patients feel more empowered, avoid treatment side-effects and reduce overtreatment.
Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.
Michigan-led research presents a new way of uncovering predictive biomarkers when data from large randomized trials aren’t available.
A 600-patient randomized clinical trial supports pembrolizumab and chemotherapy as a first-line treatment